| PDM | 8-K | mixed | 6/10 | Piedmont Realty Trust announced a proposed $200M exchangeable senior notes offering (plus $30M greenshoe) to redeem its | Sep 14, 2026 |
| HRGN | 8-K | bearish | 5/10 | Harvard Apparatus Regenerative Technology raised $2.84M via a private placement of 2,703,727 shares at $1.05/share, whic | Sep 14, 2026 |
| CABA | 8-K | neutral | 4/10 | Cabaletta Bio reports that warrants issued in a June 2025 public offering expired on September 12, 2026, and that 97% (4 | Sep 14, 2026 |
| ATEN | 8-K | neutral | 2/10 | A10 Networks appointed Mary C. Henry to its Board of Directors, expanding the board from five to six members, effective | Sep 14, 2026 |
| TDG | 8-K | neutral | 3/10 | TransDigm Group announced that its wholly-owned subsidiary, TransDigm Inc., has commenced a cash tender offer for any an | Sep 14, 2026 |
| BWIN | 8-K | bullish | 8/10 | Baldwin Insurance Group (BWIN) has entered into a definitive agreement to be acquired by entities formed by Sequence Hol | Sep 14, 2026 |
| EFC | 8-K | mixed | 5/10 | Ellington Financial announced a $100 million add-on offering of 7.375% senior unsecured notes due 2030, issued as additi | Sep 14, 2026 |
| BFRI | 8-K | bullish | 7/10 | Biofrontera announced FDA approval of its supplemental New Drug Application for Ameluz (aminolevulinic acid hydrochlorid | Sep 14, 2026 |
| BMRN | 8-K | neutral | 2/10 | BioMarin appointed Robert Plenge, M.D., Ph.D., to its Board of Directors, expanding the board from ten to eleven members | Sep 14, 2026 |
| HSTM | 8-K | neutral | 4/10 | HealthStream amended its existing $50M revolving credit facility with Truist Bank, extending the maturity from October 2 | Sep 14, 2026 |
| THRY | 8-K | bullish | 7/10 | Thryv Holdings, Inc. (THRY) has entered into a definitive agreement to sell its print directories business (Print Yellow | Sep 14, 2026 |
| DFTX | 8-K | bullish | 8/10 | Definium Therapeutics announced positive topline results from its Phase 3 Panorama study of DT120 ODT in generalized anx | Sep 14, 2026 |
| CRDF | 8-K | bullish | 6/10 | Cardiff Oncology and Nerviano Medical Sciences settled their patent inventorship litigation and amended their 2017 exclu | Sep 14, 2026 |
| MDCX | 8-K | neutral | 4/10 | Medicus Pharma Ltd. and Yorkville (YA II PN, LTD.) mutually terminated the Standby Equity Purchase Agreement (SEPA), whi | Sep 14, 2026 |
| NEWT | 8-K | neutral | 2/10 | NewtekOne, Inc. filed an 8-K on September 14, 2026, announcing a quarterly cash dividend of $0.19 per common share and a | Sep 14, 2026 |
| XBP | 8-K | bearish | 6/10 | XBP Global Holdings entered into a securities purchase agreement to sell 2,275,245 shares of common stock at a weighted | Sep 14, 2026 |
| TDG | 8-K | neutral | 4/10 | TransDigm announced a planned $2.5 billion senior secured notes offering by its subsidiary, TransDigm Inc., to refinance | Sep 14, 2026 |
| TWOH | 8-K | neutral | 2/10 | Quantum X Inc. (formerly Two Hands Corporation) filed an 8-K confirming FINRA approval of its name change to Quantum X, | Sep 14, 2026 |
| PHIO | 8-K | bullish | 5/10 | Phio Pharmaceuticals announced a key development milestone for its lead siRNA candidate PH-762, submitting a meeting req | Sep 14, 2026 |
| CELU | 8-K | mixed | 5/10 | Celularity regained compliance with Nasdaq's minimum bid price (Rule 5550(a)(2)) and minimum market value of listed secu | Sep 14, 2026 |
| KEY | 8-K | neutral | 4/10 | KeyCorp presented updated FY2026 guidance at the Barclays Global Financial Services Conference, raising its revenue grow | Sep 14, 2026 |
| ASST | 8-K | neutral | 3/10 | Strive, Inc. disclosed the purchase of 469 bitcoin for approximately $36.6 million (at ~$77,954/btc) between Sept 8-11, | Sep 14, 2026 |
| ENB | 8-K | neutral | 4/10 | Enbridge completed a public offering of 44,735,000 common shares at CDN$66.85 per share, generating approximately CDN$3. | Sep 14, 2026 |
| IMMR | 8-K | neutral | 5/10 | Immersion Corp reported Q1 FY2027 results with GAAP EPS of $0.17, significantly beating the $0.06 consensus estimate, an | Sep 14, 2026 |
| GGG | 8-K | neutral | 2/10 | Graco Inc. appointed Richard B. Lewis, President and CEO of Donaldson Company (NYSE: DCI), to its Board of Directors eff | Sep 14, 2026 |
| BNGO | 8-K | bullish | 6/10 | Bionano Genomics presented an investor deck at the H.C. Wainwright conference, highlighting Q2 2026 revenue of $8.2M (ab | Sep 14, 2026 |
| RMNI | 8-K | neutral | 3/10 | Rimini Street reinstated Steven Hershkowitz as Executive Vice President and Chief Revenue Officer effective September 14 | Sep 14, 2026 |
| PFSI | 8-K | neutral | 4/10 | PennyMac Financial Services, Inc. (PFSI) filed an 8-K furnishing an investor update presented at the Barclays Global Fin | Sep 14, 2026 |
| EOSE | 8-K | neutral | 4/10 | Eos Energy Enterprises received an $87 million advance under the second tranche of its DOE-guaranteed loan facility, bri | Sep 14, 2026 |
| DFDV | 8-K | mixed | 5/10 | DeFi Development Corp. (DFDV) announced it grew its SOL treasury by 55,491 SOL (2%) to 2,388,923 SOL as of September 11, | Sep 14, 2026 |